Maternal Plasma Fetal DNA Fractions in Pregnancies with Low and High Risks for Fetal Chromosomal Aneuploidies
暂无分享,去创建一个
Tak Y. Leung | Yuk Ming Dennis Lo | Daljit Sahota | D. Sahota | T. Leung | R. Chiu | Y. Lo | I. Hudecova | Yongjie Jin | Yongjie Jin | Irena Hudecova | Macy M. S. Heung | Wing S. Lee | Rossa W.K. Chiu | Wing-Shan Lee
[1] B. Crandall,et al. INCIDENCE AND SIGNIFICANCE OF CHROMOSOME MOSAICISM INVOLVING AN AUTOSOMAL STRUCTURAL ABNORMALITY DIAGNOSED PRENATALLY THROUGH AMNIOCENTESIS: A COLLABORATIVE STUDY , 1996, Prenatal diagnosis.
[2] J. Dungan,et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011 .
[3] S N Erné,et al. Multi‐channel magnetocardiography for detecting beat morphology variations in fetal arrhythmias , 2004, Prenatal diagnosis.
[4] K. Nicolaides,et al. Fetal fraction in maternal plasma cell‐free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[5] Jian Wang,et al. Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors , 2012, Prenatal diagnosis.
[6] M. Watson,et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy , 2013, Genetics in Medicine.
[7] Hanmin Lee,et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.
[8] A. Kurjak,et al. Noninvasive Prenatal Testing for Fetal Aneuploidy , 2013 .
[9] Yama W. L. Zheng,et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.
[10] Arnold Oliphant,et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.
[11] Stanley F. Nelson,et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study , 2012, Genetics in Medicine.
[12] K. Nicolaides,et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. , 2012, American journal of obstetrics and gynecology.
[13] T. Musci,et al. Clinical experience of noninvasive prenatal testing with cell‐free DNA for fetal trisomies 21, 18, and 13, in a general screening population , 2013, Prenatal diagnosis.
[14] K. Nicolaides,et al. Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y , 2013, Prenatal diagnosis.
[15] T K Lau,et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.
[16] C. Struble,et al. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[17] D. Sahota,et al. Comparison of likelihood ratios of first‐trimester nuchal translucency measurements: multiples of median, delta or mixture , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[18] Lin Tang,et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.
[19] K. Nicolaides,et al. Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal Factors , 2012, Fetal Diagnosis and Therapy.
[20] J. Canick,et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies , 2013, Prenatal diagnosis.
[21] L. Dugoff,et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis , 2013, Prenatal diagnosis.